Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
3/5/15 Kythera Biopharmaceuticals (KYTH) ATX-101 for Fat Removal Subscribers Only Subscribers Only Subscribers Only
3/5/15 Vanda (VNDA) Tradipitant for Pruritus Subscribers Only Subscribers Only Subscribers Only
3/5/15 Reata Pharmaceuticals Bardoxolone methyl for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
3/5/15 BioTime (BTX) AST-OPC1 for Spinal Cord Injury (SCI) Subscribers Only Subscribers Only Subscribers Only
3/4/15 Pharmacyclics (PCYC) Imbruvica for Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
Now - 03/06/15 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 03/06/15 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 03/06/15 Subscribers Only Subscribers Only Company - Earnings Announcement
03/06/15 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
03/06/15 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)